Cargando…
SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy
SARS CoV 2 S-glycoproteins play a crucial role in the entry steps of viral particles. Due to their surface location, they are the main target for host immune responses and the focus of most vaccine strategies. The D614G mutation identified in late January became dominant during March 2020, rendering...
Autores principales: | Lina, B., Bauer, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467922/ https://www.ncbi.nlm.nih.gov/pubmed/36108974 http://dx.doi.org/10.1016/j.idnow.2022.09.008 |
Ejemplares similares
-
Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco
por: Badaoui, Bouabid, et al.
Publicado: (2021) -
Genetic diversity and evolution of SARS-CoV-2
por: Phan, Tung
Publicado: (2020) -
High vaccination coverage slows down genetic diversity of SARS-CoV-2
por: Liu, Yuqi, et al.
Publicado: (2022) -
Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview
por: Hadizadeh, Nastaran, et al.
Publicado: (2022) -
Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)